Adverse effects associated with favipiravir in patients with COVID-19 pneumonia: a retrospective study.

Background: Favipiravir is generally used in treating coronavirus disease 2019 (COVID-19) pneumonia in Turkey.

Objective: To determine the side effects of favipiravir and whether it is a good treatment option.

Design And Setting: Retrospective study conducted in Atatürk Chest Diseases and Chest Surgery Training and Research Hospital, Ankara, Turkey.

Preoperative pulmonary evaluation of liver transplant candidates: results from 341 adult patients.

Background: Pulmonary disorders are among the commonly encountered and prognostically important problems in patients with chronic liver disease. To define the prevalence and types of respiratory disorders in patients with advanced liver disease evaluated for liver transplant (LT) candidacy, and to determine factors affecting postoperative outcome.

Material/methods: The records of 341 adult patients evaluated for LT candidacy were retrospectively examined.

The prevalence and the impact of portopulmonary hypertension on postoperative course in patients undergoing liver transplantation.

Introduction: Portopulmonary hypertension (PPH) is an uncommon but serious complication of chronic liver disease. It is accepted to be a poor prognostic factor in the follow-up of patients who have undergone orthotopic liver transplantation (OLT). The presence of severe PPH is accepted as a contraindication to OLT.